Analyst Divide Deepens on Ams Osram: JPMorgan Doubles Target While Consensus Lags Behind Runaway Rally
19.06.2026 - 01:11:39 | boerse-global.de
The gulf between what some analysts see in Ams Osram and what the broader consensus believes is growing wider by the day. JPMorgan has doubled its price target on the Austrian-German chipmaker to 23.60 Swiss francs and upgraded the stock from Neutral to Overweight, yet the average analyst target sits at just 14.82 francs — a level the shares have already blown past. The current price of around €19.80 to €20.10 puts the company roughly 26% below its 52-week high of €26.70, but the dispersion of estimates, ranging from 7.07 francs to that same 23.60 francs, underscores just how polarised the investment case has become.
At the heart of that divergence sits a half-built factory in Kulim, Malaysia, and a €400 million liability that could either vanish or keep weighing on the balance sheet. The facility was constructed for a key customer who later abandoned a MicroLED project, leaving a fully equipped plant with no tenant. The idle site is burning through a double-digit million euro sum each year in ongoing costs, and management is actively scouting for a buyer or lessee. Should a deal materialise, roughly €400 million in long-term liabilities would be stripped from the books — a shot in the arm for a turnaround story that has already seen shares climb about 133% since the start of the year.
But the Kulim overhang is only one of two major balance-sheet catalysts on the horizon. The planned sale of Ams Osram’s non-optical sensor business to Infineon for €570 million in cash is awaiting a decision from Germany’s Federal Cartel Office, which has been reviewing the transaction since 3 March 2026. A ruling is expected within the current quarter. If approved, the company’s leverage ratio would drop from 3.3 to roughly 2.5, and combined with other divestments totalling around €670 million, annual financing costs could be sliced from as much as €300 million to below €150 million by 2028. The shares took a breather in recent sessions, but the antitrust verdict is widely seen as the next major inflection point for the stock.
The operational foundation underpinning the rally is solid enough. For the first quarter of 2026, Ams Osram reported revenue of €796 million and an adjusted EBITDA margin of 16.5%, landing at the top end of its own guidance. Core semiconductor sales grew 9% on a comparable basis, and free cash flow swung positive to €37 million from a negative €28 million a year earlier. For the full year, management forecasts a slight dip in revenue driven by currency headwinds and disposals, but aims to keep free cash flow above €300 million when divestment proceeds are included. By 2027, the company expects to generate positive free cash flow without relying on such one-off inflows.
Should investors sell immediately? Or is it worth buying Ams Osram?
On the growth front, the strategic pivot toward digital photonics for artificial intelligence data centres is gaining traction. During an investor conference, Ams Osram presented concrete progress on micro-emitter arrays developed with a leading infrastructure partner. These chips are designed to make data transfer between high-performance processors far more energy-efficient, starting with short-range links between server racks and eventually expanding to intra-rack and chip-to-chip connections. Chief financial officer Rainer Irle has pegged the long-term revenue opportunity in the high hundreds of millions of euros, though he cautions that meaningful contributions are unlikely before 2030.
Regulatory tailwinds are also building. The European Commission’s proposed Chips Act 2.0, unveiled in June 2026, aims to bolster domestic semiconductor production and reduce strategic dependencies. Ams Osram’s site in Premstätten, Austria, is positioning itself as a foundry for small and medium-sized enterprises, focusing on custom chips for industrial and defence applications — a niche that could benefit from the act’s subsidised capacity.
Meanwhile, shareholders have thrown their weight behind the board. At the annual general meeting on 10 June, all agenda items passed with support ranging from 83.65% to 100%. Supervisory board members Andreas Gerstenmayer and Arunjai Mittal were re-elected until 2030, sending a clear signal of continuity as the company navigates its twin-track transformation.
Ams Osram at a turning point? This analysis reveals what investors need to know now.
For now, the stock trades around €19.80 to €20.10, having rallied more than 136% year to date. The path forward will be shaped by two binary events: the Cartel Office’s green light for the Infineon sale would materially lighten the debt load, while a lease or sale of the empty Kulim facility could erase that €400 million worry. Between those levers and the nascent AI photonics opportunity, the analyst consensus may soon need to play catch-up — or the market will decide that the gap is justified.
Ad
Ams Osram Stock: New Analysis - 19 June
Fresh Ams Osram information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
